Abstract
There is substantial epidemiologic data, but limited experimental data, supporting the mortality benefit of low-dose alcohol consumption. A regimen of a single, daily alcoholic beverage was sufficient to increase both high-density lipoprotein (HDL) (4.4%, p = 0.03) and HDL2 (7.7%, p = 0.04) in men and women, but did not significantly affect hemostatic markers of cardiovascular risk.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adult
-
Alcohol Drinking*
-
Beer
-
Blood Coagulation Factors / analysis*
-
Cardiovascular Diseases / blood*
-
Cardiovascular Diseases / epidemiology*
-
Cholesterol, HDL / blood*
-
Female
-
Humans
-
Lipoproteins / blood*
-
Male
-
Middle Aged
Substances
-
Blood Coagulation Factors
-
Cholesterol, HDL
-
Lipoproteins